Journal
BIOCONJUGATE CHEMISTRY
Volume 30, Issue 11, Pages 2870-2878Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.9b00578
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [NSFC 21778003, NSFC U186720011]
- Ministry of Science and Technology of the People's Republic of China [2017YFA0506300]
- Intramural Research Program, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health
Ask authors/readers for more resources
Boronophenylalanine (BPA) is the dominant boron delivery agent for boron neutron capture therapy (BNCT), and [F-18]FBPA has been developed to assist the treatment planning for BPA-BNCT. However, the clinical application of BNCT has been limited by its inadequate tumor specificity due to the metabolic instability. In addition, the distinctive molecular structures between [F-18]FBPA and BPA can be of concern as [F-18]FBPA cannot quantitate boron concentration of BPA in a real-time manner. In this study, a metabolically stable boron-derived tyrosine (denoted as fluoroboronotyrosine, FBY) was developed as a theranostic agent for both boron delivery and cancer diagnosis, leading to PET imaging-guided BNCT of cancer. [F-18]FBY was synthesized in high radiochemical yield (50%) and high radiochemical purity (98%). FBY showed high similarity with natural tyrosine. As shown in in vitro assays, the uptake of FBY in murine melanoma B16-F10 cells was L-type amino acid transporter (LAT-1) dependent and reached up to 128 mu g/10(6) cells. FBY displayed high stability in PBS solution. [F-18]FBY PET showed up to 6 %ID/g in B16-F10 tumor and notably low normal tissue uptake (tumor/muscle = 3.16 +/- 0.48; tumor/blood = 3.13 +/- 0.50; tumor/brain = 14.25 +/- 1.54). Moreover, administration of [F-18]FBY tracer along with a therapeutic dose of FBY showed high accumulation in B16-F10 tumor and low normal tissue uptake. Correlation between PET-image and boron biodistribution was established, indicating the possibility of estimating boron concentration via a noninvasive approach. At last, with thermal neutron irradiation, B16-F10 tumor-bearing mice injected with FBY showed significantly prolonged median survival without exhibiting obvious systemic toxicity. In conclusion, FBY holds great potential as an efficient theranostic agent for imaging-guided BNCT by offering a possible solution of measuring local boron concentration through PET imaging.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available